Use of axillary ultrasound to guide breast cancer management in the genomic assay era

CONCLUSION: A cut-off of ≤5 ultrasound-detected abnormal nodes can distinguish between patients with limited versus high nodal burden, with high specificity. Hence, incorporating the number of abnormal ultrasound-detected nodes into clinical practice may prove useful in guiding between upfront surgery and gene assay testing or neoadjuvant chemotherapy in this group of patients.PMID:38489166 | DOI:10.3233/BD-230032

Source: Breast Disease - March 15, 2024 Category: Cancer & Oncology Authors: Geok Hoon Lim John Carson Allen Yien Sien Lee Sze Yiun Teo Li Ching Lau Thida Win Lester Chee Hao Leong Source Type: research